Source: International Congress 2016 – New therapies and therapeutic targets
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Matt Thomas (Gothenburg, Sweden), Matt Thomas, Peter Bold, Karin Bjorhall, Andrew Butcher, Johan Carlsson, Paulina Cygan, Maria Karlsson, Helena Lindmark, Rose Maciewicz, Mickael Mogemark, Vikki Morrison, Maria Nordberg, Matthew Perry, Sandra Rodrigo Blomqvist, Carla Winkler, Carl Goodyear, Kostas Karabelas. Redefining the asthma treatment paradigm using a locally administered dual PI3Kgd inhibitor. Eur Respir J 2016; 48: Suppl. 60, 468

Member's Comments

No comment yet.

Related content which might interest you: In vitro profile of the new inhaled pan-JAK inhibitor LAS194046 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Inhibition of JAK/STAT pathway in airway epithelium as a potential targeted therapy of asthma Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 New outlook on the Th1/Th2-alternative signaling pathways in asthma Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013 Therapeutic potential of CPL-407-105 – Novel potent JAK/STAT pathway inhibitor for the treatment of asthma Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Applying the 3Rs to asthma research Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 In vitro characterization of a novel inhaled PI3Kd inhibitor LAS194223 Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 QAW039, a slowly dissociating CRTh2 antagonist with potential for improved clinical efficacy Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014 Antioxidant efficiency in the treatment of asthma exacerbations Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 ALX-0962, an anti-IgE Nanobody® with a dual mode of action Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Pharmacological profile and efficacy of GLPG1690, a novel ATX inhibitor for COPD treatment Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 RP6503, a novel and selective PI3K δ/gamma inhibitor, potentiates the effect of steroids in pre-clinical models of COPD Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 LATE-BREAKING ABSTRACT: Inhibition of RC kinase is a novel therapeutic approach for the treatment of COPD and IPF Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Different roles for PI3Kgamma and δ in asthma Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Novel, highly potent and selective JAK3 inhibitor disrupting IL-4/IL-13 signaling in asthma therapy Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Preclinical characterization of CPL-302-201, a novel, highly potent and selective PI3Kδ inhibitor for the treatment of inflammatory disorders Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Chronic dosing effects of propranolol in asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 The inverse agonist propranolol does not confer steroid-sparing activity in persistent asthma Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 B cells in a murine model of allergic asthma and respiratory tolerance Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015